1. Home
  2. CVM vs VVOS Comparison

CVM vs VVOS Comparison

Compare CVM & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • VVOS
  • Stock Information
  • Founded
  • CVM 1983
  • VVOS 2016
  • Country
  • CVM United States
  • VVOS United States
  • Employees
  • CVM N/A
  • VVOS N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • VVOS Medical Specialities
  • Sector
  • CVM Health Care
  • VVOS Health Care
  • Exchange
  • CVM Nasdaq
  • VVOS Nasdaq
  • Market Cap
  • CVM 18.1M
  • VVOS 17.5M
  • IPO Year
  • CVM 1987
  • VVOS 2020
  • Fundamental
  • Price
  • CVM $9.45
  • VVOS $5.18
  • Analyst Decision
  • CVM
  • VVOS Strong Buy
  • Analyst Count
  • CVM 0
  • VVOS 2
  • Target Price
  • CVM N/A
  • VVOS $6.10
  • AVG Volume (30 Days)
  • CVM 2.0M
  • VVOS 477.2K
  • Earning Date
  • CVM 08-14-2025
  • VVOS 08-13-2025
  • Dividend Yield
  • CVM N/A
  • VVOS N/A
  • EPS Growth
  • CVM N/A
  • VVOS N/A
  • EPS
  • CVM N/A
  • VVOS N/A
  • Revenue
  • CVM N/A
  • VVOS $14,628,000.00
  • Revenue This Year
  • CVM N/A
  • VVOS $3.83
  • Revenue Next Year
  • CVM N/A
  • VVOS $25.27
  • P/E Ratio
  • CVM N/A
  • VVOS N/A
  • Revenue Growth
  • CVM N/A
  • VVOS 9.47
  • 52 Week Low
  • CVM $1.98
  • VVOS $1.97
  • 52 Week High
  • CVM $39.30
  • VVOS $7.95
  • Technical
  • Relative Strength Index (RSI)
  • CVM 74.98
  • VVOS 54.97
  • Support Level
  • CVM $7.02
  • VVOS $5.17
  • Resistance Level
  • CVM $9.76
  • VVOS $5.94
  • Average True Range (ATR)
  • CVM 1.31
  • VVOS 0.59
  • MACD
  • CVM 0.45
  • VVOS -0.24
  • Stochastic Oscillator
  • CVM 86.62
  • VVOS 36.43

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: